USS Investment Management Ltd Has $9.60 Million Position in Cardinal Health, Inc. $CAH

USS Investment Management Ltd grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,435 shares of the company’s stock after buying an additional 3,580 shares during the quarter. USS Investment Management Ltd’s holdings in Cardinal Health were worth $9,600,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $25,000. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $26,000. Bank of Jackson Hole Trust acquired a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $27,000. Jones Financial Companies Lllp grew its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares in the last quarter. Finally, Palladiem LLC bought a new position in shares of Cardinal Health in the fourth quarter valued at $28,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of CAH stock opened at $238.31 on Thursday. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $240.93. The company has a market capitalization of $55.82 billion, a price-to-earnings ratio of 36.44, a PEG ratio of 1.30 and a beta of 0.48. The company has a 50-day simple moving average of $207.54 and a 200 day simple moving average of $211.22.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period last year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s payout ratio is 31.19%.

Analyst Upgrades and Downgrades

CAH has been the topic of several analyst reports. Evercore dropped their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Morgan Stanley lifted their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. William Blair assumed coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating on the stock. JPMorgan Chase & Co. dropped their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Finally, Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 15th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus target price of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.